Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion

Drug Test Anal. 2018 Mar;10(3):604-608. doi: 10.1002/dta.2240. Epub 2017 Aug 9.

Abstract

Autologous blood transfusion is a powerful means of improving performance and remains one of the most challenging methods to detect. Recent investigations have identified 3 candidate reticulocytes genes whose expression was significantly influenced by blood transfusion. Using quantitative reverse transcription polymerase chain reaction as an alternative quantitative method, the present study supports that delta-aminolevulinate synthase 2 (ALAS2), carbonic anhydrase (CA1), and solute carrier family 4 member 1 (SLC4A1) genes are down-regulated post-transfusion. The expression of these genes exhibited stronger correlation with immature reticulocyte fraction than with reticulocytes percentage. Moreover, the repression of reticulocytes' gene expression was more pronounced than the diminution of immature reticulocyte fraction and reticulocyte percentage following blood transfusion. It suggests that the 3 candidate genes are reliable predictors of bone marrow's response to blood transfusion and that they represent potential biomarkers for the detection of this method prohibited in sports.

Keywords: IRF; transcriptomics; transfusion.

MeSH terms

  • 5-Aminolevulinate Synthetase / genetics
  • Adult
  • Anion Exchange Protein 1, Erythrocyte / genetics
  • Blood Transfusion, Autologous* / methods
  • Carbonic Anhydrase I / genetics
  • Doping in Sports* / methods
  • Down-Regulation
  • Erythropoiesis*
  • Humans
  • Male
  • Reticulocytes / cytology
  • Reticulocytes / metabolism
  • Transcriptome*

Substances

  • Anion Exchange Protein 1, Erythrocyte
  • SLC4A1 protein, human
  • 5-Aminolevulinate Synthetase
  • ALAS2 protein, human
  • Carbonic Anhydrase I